Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date.
about
Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review.Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switchSafety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trialThe Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationaleThe safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.Tailoring of corticosteroids in COPD management.Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study.
P2860
Q30620671-4FC9E465-4A48-46BF-99C0-904593EEA564Q33949299-32F799A3-095F-4A5B-A001-B4901745A513Q34944616-D802BCCB-A5B8-4E3B-A097-B3BD5832D9C0Q36456873-0E5113D9-5F93-4D76-97F8-BF00816B57F4Q36752114-FE0BB211-4A19-4B8B-A5DB-DFDB31082904Q38592062-1B16FA51-862F-41F9-A218-2A3BB3FE7DEFQ42753079-99FCAC66-9643-4B2E-BC81-8696F146E53CQ48014456-EA62D453-A9CC-4DDB-8FA7-4A54BF3E48BA
P2860
Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Risks associated with tiotropi ...... rview of the evidence to date.
@ast
Risks associated with tiotropi ...... rview of the evidence to date.
@en
type
label
Risks associated with tiotropi ...... rview of the evidence to date.
@ast
Risks associated with tiotropi ...... rview of the evidence to date.
@en
prefLabel
Risks associated with tiotropi ...... rview of the evidence to date.
@ast
Risks associated with tiotropi ...... rview of the evidence to date.
@en
P2860
P356
P1476
Risks associated with tiotropi ...... rview of the evidence to date.
@en
P2093
Yoon K Loke
P2860
P304
P356
10.1177/2042098612438388
P50
P577
2012-06-01T00:00:00Z